Publication | Open Access

Rationale and Design of the DIPAK 1 Study: A Randomized Controlled Clinical Trial Assessing the Efficacy of Lanreotide to Halt Disease Progression in Autosomal Dominant Polycystic Kidney Disease

UrologyMedicineKidney FailureRenal PathologyPathologyDipak 1Halt Disease ProgressionChronic Kidney DiseaseNephrologyKidney ResearchClinical Genetics